Author

H. Kalam

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:imaging· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

D. Kumar· 1 shared L. Singh· 1 shared N. Jain· 1 shared P. Das· 1 shared S. Kedia· 1 shared V. Ahuja· 1 shared V. Sharma· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

D. Kumar

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Mesenchymal stem cells (MSCs) offer a drug tolerant and immune-privileged niche to Mycobacterium tuberculosis

N. Jain, H. Kalam, L. Singh, V. Sharma, S. Kedia, P. Das, V. Ahuja, D. Kumar

This study shows mesenchymal stem cells (MSCs) provide a drug-tolerant and immune-privileged niche for Mycobacterium tuberculosis, with implications for tuberculosis treatment.

bioRxiv · Jan 16, 2019Immunology